Conference
Real-world effectiveness of pegylated, recombinant antihaemophilic factor (Rurioctocog alfa pegol) prophylaxis in patients with haemophilia A in Canada: A retrospective, intra-patient comparison with a before-after design
Authors
Keepanasseril A; Klaassen R; Teitel J; James P; Carcao M; Ibrahim Q; Iserman E; Blaser H; Iorio A
Volume
30
Pagination
pp. 35-38
Publisher
WILEY
Publication Date
April 1, 2024
Conference proceedings
HAEMOPHILIA
ISSN
1351-8216